Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
Aim. To evaluate the efficacy and safety of the Russian biosimilar infliximab in patients with ulcerative colitis (UC). Materials and methods. This is a retrospective study of stable patients with UC, who are followed up at the department of bowel pathology of Loginov Moscow Clinical Scientific C...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
"Consilium Medicum" Publishing house
2025-01-01
|
| Rangatū: | Терапевтический архив |
| Ngā marau: | |
| Urunga tuihono: | https://ter-arkhiv.ru/0040-3660/article/viewFile/646287/193077 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|